Mayo Clinic Laboratories > Pediatrics > Infectious Diseases

Infectious Diseases

Elevate outcomes through expert-developed testing

Rising global temperatures have caused a shift in climate zones and triggered a migration of infectious disease-carrying species into previously uninhabitable climate zones,1 broadening the impact of the diseases they carry. For children who become infected with bacterial, viral, fungal, or parasitic pathogens — many of which are passed to humans by insects — early identification of the infectious agent enables rapid intervention to pave the way for healing.

Our internationally renowned clinical microbiology laboratories’ robust menu of infectious disease testing includes individual tests and panels that aid in diagnosing illnesses caused by insects, fungal species, and parasites.

Test menu

Fungal infections Fungal infections
Fungal infections

Mayo Clinic Laboratories’ fungal diagnostics test menu includes molecular and serological assays to aid in diagnosing a wide variety of fungal diseases, including those caused by Coccidioides posadasii/immitis, Histoplasma, Blastomyces, and Aspergillus, among others.

Gastrointestinal pathogens Gastrointestinal pathogens
Gastrointestinal pathogens

Our gastrointestinal pathogen panel is a multiplex polymerase chain reaction (PCR) test capable of rapidly and qualitatively detecting the DNA or RNA of 22 pathogens.

Helicobacter pylori Helicobacter pylori
Helicobacter pylori

As the main cause of peptic ulcer disease and a major risk factor for gastric cancer, H. pylori can lead to life-threatening medical conditions if left untreated. Timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.

Mosquito-borne diseases Mosquito-borne diseases
Mosquito-borne diseases

We offer a comprehensive menu of individually orderable tests and panels for mosquito-borne diseases (MBDs). Additionally, our algorithmic approaches to MBD testing help reduce costs and optimize patient care.

Tick-borne diseases Tick-borne diseases
Tick-borne diseases

We offer a full menu of individual tests and panels that aid in the diagnosis of tick-borne diseases (TBDs). In addition to our comprehensive testing menu, we have developed multiple TBD testing algorithms, including modified two-tiered assays, to help guide and optimize diagnostic testing.

News and updates

The latest

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children.

Learn more
Improving diagnosis and treatment of Helicobacter pylori

Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.

Helicobacter pylori testing: 2021 update

In this month’s Hot Topic, Robin Patel, M.D., discusses Mayo Clinic Laboratories’ new PCR assay for detection of Helicobacter pylori detection and determination of clarithromycin resistance directly from stool.

Thank you to all our staff during the time of COVID-19

Thank you to our staff at Mayo Clinic who step up daily during this time of need to provide access to testing during the global pandemic. We appreciate each one of you and all the sacrifices you personally have made throughout this past year.

Molecular Detection for Tuberculosis Drug Resistance [Test in Focus]

Nancy Wengenack, Ph.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken due to the results of this testing.

References
  1. Philson C, Gray L, Pedroncelli L, Ota W. Mitigating climate change’s impact on tick-borne zoonotic disease emergence. J Sci Policy Gov. Vol. 19, Issue 1, Nov. 2021. https://doi.org/10.38126/JSPG190109
INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.

Are you a patient? Click here.